The role of bactericidal/permeability-increasing protein in men with chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 9, Issue 2, 2012, Pages 197-202

  Chen, Chiung Zuei ^a   Ou, Chih Ying ^a   Wang, Ru Hsueh ^a   Lee, Cheng Hung ^a   Lin, Chien Chung ^a   Chang, Han Yu ^a   Hsiue, Tzuen Ren ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Bactericidal permeability increasing protein; COPD; Llipopolysaccharides; Ppolymorphism

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SMOKING;

ADULT; AGED; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD PROTEINS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING;

EID: 84859320176     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2011.654143     Document Type: Article

References (29)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, updated. Bethesda, MD: National Heart, Lung and Blood Institute/World Health Organization, 2008 (http://www.goldcopd.org).
2. Tan WC, Ng TP. COPD in Asia: Where East meets West. Chest 2008; 133:517-527. (Pubitemid 351272413)
3. Regional COPD Working Group. COPD prevalence in 12 Asia- Pacifi c countries and regions: Projections based on the COPD prevalence estimation model. Respirology 2003; 8:192-198.
4. Vogelzang PFJ, Van der Gulden JW, Folgering H, Kolk JJ, Heederik D, Preller L, Tielen MJM, Van Schayck CP (1998) Endotoxin exposure as a major determinant of lung function decline in pig farmers. Am J Respire Crit Care Med 1998; 157:15-18. (Pubitemid 28071255)
5. Th orne PS, Kulhankova K, Yin M, Cohn R, Arbes SJ, and Zeldin DC. Endotoxin exposure is a risk factor for asthma; the national survey of endotoxin in United States housing. Am J Respire Crit Care Med 2005; 172:1371-1377. (Pubitemid 43069809)
6. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999; 115:829-835. (Pubitemid 29129968)
7. Russell RE, Culpitt SV, Dematos C, Donnely L, Smith M, Wiggins J, Barnes PJ. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloprotease-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respire Cell Mol Biol 2002; 26:602-609. (Pubitemid 34315869)
8. Lim S, Roche N, Oliver BG, Mattos W, Barnes PJ, Chung KF. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. Am J Respir Crit Care Med 2000; 162(pt1):1355-1360.
9. Vernooy JH, Dentener MA, Van Suylen RJ, Buurman WA, Wouters FM. Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung infl ammation and persistent pathology. Am J Respir Cell Mol Biol 2002; 26:152-159. (Pubitemid 34029832)
10. Sajjan U, Ganesan S, Comstock AT, Shim J, Wang Q, Nagarkar DR, Zhao Y, Doldsmith AM, Sonestein J, Linn MJ, Curtis JL, Hershenson MB. Elastase- and LPS- exposed mice display altered responses to rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 2009; 297:L931-L944.
11. Meng QR, Gideon KM, Harbo SJ, Renne RA, Lee MK. Gene expression profi ling in lung tissue from mice exposed to cigarette smoke, lipopolysaccharide, or smoke plus lipopolysaccharide by inhalation. Inhal Toxicol 2006; 18:555-568.
12. Wittmann I, SchÖnefeld M, Aichele D, Groer G, Gessner A, Schnare M. Murine bactericidal/permeability-increasing protein inhibits the endotoxic activity of lipopolysaccharide and gram-negative bacteria. J Immunol 2008; 180:7546-7552.
13. Weiss J. Bactericidal/permeability-increasing protein (BPI): structure, function and regulation in host defense against Gram-negative bacteria. Biochem Soc Trans 2003; 31:785
14. Chien JW, Zhao LP, Hansen JA, Fan WH, Parimon T, Clark JG. Genetic variation in bactericidal/permeability- increasing protein infl uences the risk of developing rapid airfl ow decline after hematopoietic cell transplantation. Blood 2006; 107:2200-2207. (Pubitemid 43289407)
15. Levy O. A neutrophil-derived anti-infective molecule: Bactericidal/permeability-ßßincreasing protein. Antimicrob Agents Chemother 2000; 44:2925-2931.
16. Ruiz A.G, Casafont F, Teran A, De La Pena J, Estebanez A, Romero FP. Increased bactericidal/permeability increasing protein in patients with cirrhosis. Liver Int 2010; 30:94-101.
17. Groenewegen KH, Dentener MA, Wouters EFM. Longitudinal follow-up of systemic infl ammation after acute exacerbatio of COPD. Respir Med 2007; 101:2409-2415. (Pubitemid 47471393)
18. Hubacek JA, Stuber F, Frohlich D, Book M, Wetegrove S, Ritter M, Rothe G, Schmitz G. Gene variants of the bactericidal/permeability-increasing protein and lipopolysaccharide binding protein in sepsis patients. Crit Care Med 2001; 29:557-566.
19. Hubacek JA, Aslanidis C, Buchler C, Schmitz G. PstIpolymorphismin the human bactericidal permeability increasing protein (BPI) gene. Clin Genet: 1979; 52:249.
20. Maris NA, de Vos A.F, Dessing MC, Spek CA, Lutter R, Jansen HM, Van der Zee JS, Bresser P, Van der Poll T. (2005) Antiinfl ammatory Effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med 2005; 172:878-884. (Pubitemid 41369072)
21. Krawczak M, Reiss J, Cooper DN. The mutational spectum of single base-pair substitutions in mENA splice junctions of human genes: causes and consequences. Hum Genet 1992; 90:41-54.
22. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: Exonic mutations that aff ect splicing. Natrue Rev Genet 2002; 3:285-298. (Pubitemid 34279797)
23. Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, Epplen J, Schmeiegel W, Griga T. A polymorphism of the bacterial/permeability protein gene is associated with Crohn's disease. J Clin Gastroenterol 2005; 39:282-283. (Pubitemid 40393241)
24. Yang P, Tremanine WJ, Meyer RL, Prakash UB. Alpha 1-antitrypsin defi ciency and infl ammatory bowel diseases. Mayo Clin Proc 2000; 75: 450-455.
25. Ekbom A, Brandt L, Granath F, Lofdahl C-G, Egesten A. Increased risk of both ulcerative colitis and Crohn's disease in a population suff ering from COPD. Lung 2008; 186: 167-172.
26. Sinden NJ, Stockley RA. Systemic infl ammation and comorbidity in COPD: a result of overspill of inflammatory mediators from the lungs? Review of the evidence. Thorax 2010; 65:930-936.
27. Eagan TML, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damas JK, Aukrust P, Bakke PS. Systemic infl ammatory markers in COPD: results from the Bergen COPD cohort study. Eur Respir J 2010; 35:540-548.
28. Walter RE, Wilk JB, Larson MG, Vasan RS, Keaney JF, Lipinska I, O'Connor GT, Benjamin EJ. Systemic infl ammation and COPD. The Framingham heart study. Chest 2008; 133: 19-25.
29. Levin M, Quint PA, Goldstein B, Barton P, Bradley JS, Shemie SD, Yeh T, Kim SS, Cafaro DP, Scannon PJ, Giroir BP. Recombinant bactericial/permeability- increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomized trial. Lancet 2000; 356:961-967.